PULMATRIX, INC. Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
PULMATRIX, INC. (PULM) reported Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions of $130.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-30.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions · last filed 2023-03-30
- PULMATRIX, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2021 was $130.00K, a 7.44% increase from fiscal 2020.
- PULMATRIX, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2020 was $121.00K, a 90.27% decline from fiscal 2019.
- PULMATRIX, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2019 was $1.24M.
- PULMATRIX, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2017 was $122.00K.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month |
|---|---|
| 2021-12-31 | $130.00K 10-K · filed 2023-03-30 |
| 2020-12-31 | $121.00K 10-K · filed 2022-03-29 |
| 2019-12-31 | $1.24M 10-K · filed 2021-03-23 |
| 2017-12-31 | $122.00K 10-K · filed 2019-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |